financetom
Business
financetom
/
Business
/
Foot Locker Q2 Earnings: Revenue And EPS Beat, Multiple Store Closures, Inventory Falls 10% And More
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Foot Locker Q2 Earnings: Revenue And EPS Beat, Multiple Store Closures, Inventory Falls 10% And More
Aug 29, 2024 9:20 AM

Foot Locker, Inc ( FL )  stock tumbled in the premarket session on Thursday. The company reported a second-quarter adjusted EPS loss of 5 cents, beating the analyst consensus estimate of 7-cent loss. Quarterly sales of $1.896 billion beat the street view of $1.888 billion.

Also Read: Goldman Sachs Highlights Foot Locker's Digital Rebound And Costco's New Membership Crackdown

Total sales increased 1.9% year over year. The comparable sales grew by 2.6%, which was led by 5.2% growth in global Foot Locker ( FL ) and Kids Foot Locker comparable sales.

During the quarter, the company opened five new stores and closed 31. It also remodeled or relocated 14 stores and updated 67 stores to current design standards. Inventory decreased 10.0% year over year.

Foot Locker's ( FL ) gross margin increased by 50 basis points, including a 40-basis point drag from the non-recurring FLX Rewards Program charge. Quarterly adjusted net loss was $(4) million, compared with $4 million profit in the corresponding prior-year period.

At quarter-end, the company's cash and cash equivalents totaled $291 million, while total debt was $445 million.

As of August 3, the company operated 2,464 stores in 26 countries in North America, Europe, Asia, Australia, and New Zealand.

In addition, 213 franchised stores were operating in the Middle East and Asia.

CEO Mary Dillon: "The Lace Up Plan is working, as evidenced by our return to positive total and comparable sales growth as well as gross margin expansion in the second quarter.  Our top line trends strengthened as we moved through the quarter, including a solid start to Back-to-School." 

Outlook: The company reiterated fiscal 2024 adjusted EPS guidance of $1.50-$1.70 versus the $1.54 consensus.

Foot Locker ( FL ) maintained sales change of (1%)-1% in fiscal 2024 year over year, or $8.072 billion—$8.236 billion versus the consensus of $8.130 billion.

Gross Margin guidance stands at 29.5%- 29.7% (prior 29.8%- 30.0%) to reflect promotional pressure in international and WSS.

Foot Locker ( FL ) stock has gained over 77% in the last 12 months.

Price Action: FL stock traded lower by 8.11% to $30.15 premarket at the last check on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Weapons makers have 'conned' US military into buying expensive equipment, Army Secretary says
Weapons makers have 'conned' US military into buying expensive equipment, Army Secretary says
Nov 14, 2025
WASHINGTON (Reuters) -Large defense companies have conned the U.S. military into buying expensive equipment when cheaper commercial options would have been available, U.S. Army Secretary Dan Driscoll said. Government accountability advocates and some lawmakers have long argued that defense contractors have overcharged the military. But Driscoll's comments were unusually blunt for a sitting government official speaking out against companies that...
BMO Says Canadian Consumer Insolvencies Back to Pre-Pandemic Highs
BMO Says Canadian Consumer Insolvencies Back to Pre-Pandemic Highs
Nov 14, 2025
06:02 AM EST, 11/14/2025 (MT Newswires) -- Canadian consumer insolvencies have continued to march up from their pandemic-era lows, said Bank of Montreal (BMO). As of September, the 12-month pace has reached its pre-pandemic highs of around 11,600, noted the bank. Given elevated household debt and upward pressure from mortgage resets, it's perhaps heartening to see insolvencies haven't risen even...
Inhibrx Biosciences' Q3 net loss widens, misses EPS estimates
Inhibrx Biosciences' Q3 net loss widens, misses EPS estimates
Nov 14, 2025
Overview * Inhibrx Q3 net loss widens, missing analyst expectations for EPS and net income * R&D expenses decreased due to reduced process development and headcount * Cash and cash equivalents decreased to $153.1 mln from $186.6 mln in Q2 2025 Outlook * Inhibrx plans to submit a biologics license application in Q2 2026 * Interim data shows high response...
Judge to weigh if Texas AG can block Kenvue dividend over Tylenol
Judge to weigh if Texas AG can block Kenvue dividend over Tylenol
Nov 14, 2025
* Paxton says Kenvue ( KVUE ) should save money because of lawsuits * Kenvue ( KVUE ), J&J, doctors say Tylenol is safe * Paxton says 'wealth of evidence' suggests autism link By Jonathan Stempel Nov 14 (Reuters) - A Texas judge on Friday will consider state Attorney General Ken Paxton's bid to block Kenvue ( KVUE ) from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved